Research
Cellular
GLP-1 receptor agonist patients demonstrated higher overall complication rates (20%) compared to controls (10%), though this was not statistically significant (p=0.47).
Clinicians should be aware of the potential for higher complication rates in patients using GLP-1 receptor agonists.
StrongQualifiesmedium confidence
GLP-1 patients demonstrated numerically higher overall complication rates compared to the controls (20% vs. 10%, p=0.47).
Why this rating
Based on a retrospective comparative case series design.
Source
Breast implant explantation with mastopexy in patients using GLP-1 receptor agonizts: A retrospective comparative analysis
Or Friedman et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 2025
DOI 10.1016/j.bjps.2025.09.028
other · n=60Cited 5×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonist patients experienced greater weight loss (7.8 kg) compared to controls (0.5 kg), with statistical significance (p<0.001).Strong
- GLP-1 receptor agonist patients had significantly lower serum albumin (4.06 g/dL) and prealbumin levels (23.52 mg/dL) compared to controls (4.22 g/dL and 25.55 mg/dL, respectively).Strong
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →